EARLY-STAGE INNOVATIONS | ACADEMIA-INDUSTRY COLLABORATIONS | TECHNOLOGY TRANSFER | SEED INVESTMENT 

With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.

WHY ATTEND BIOFIT?

Out of 1,000 BioFIT attendees, 1,000 deals have been generated. The breakdown in terms of nature of deals is the following:

• 35% of collaborative research projects
• 30% of licensing deals
• 15% of equity investment deals
• 20% of services deals

Estimate based on the measurement of 2015 and 2016 delegates’ outcomes

KEY FIGURES:

• 1,200+ delegates
• 800+ organisations
• 35+ countries represented
• 1,000 deals generated in 2017

INSIDE THE EVENT:

• A business convention with pre-qualified one-to-one meetings (partneringONE platform from EBD Group)
• Identification of would-be CEOs
• Conferences and roundtable discussions
• Oral presentations of start-ups and licensing opportunities stemming from academia
• An exhibition area
• Informal networking evenings

Website: www.biofit-event.com
Twitter: @BIOFIT_EVENT

Contact:
Margaux Satola
Business Development Manager
msatola@eurasante.com
+33 (0)3 59 39 01 82